Ā | Group I (n = 30) | Group II (n = 30) | Group III (n = 20) | Test of Sig. | P |
---|---|---|---|---|---|
Gender | |||||
āMale | 19 | 15 | 7 | Ļ2 = 3.886 | 0.143 |
āFemale | 11 | 15 | 13 | ||
Age (years) | |||||
āMin-Max | 28.0ā70.0 | 36.0ā79.0 | 21.0ā45.0 | F = 39.150* | <ā0.001* |
āMean Ā± SD | 48.0 Ā± 11.06 | 55.47Ā±12.62 | 28.60Ā±5.36 | ||
āMedian (IQR) | 45.50(39.0ā57.0) | 54.0(45.0ā67.0) | 28.0(25.50ā31.0) | ||
Degree of ascites | |||||
āMild | - | 9 | - | 30 | - |
āModerate | - | 9 | - | 30 | |
āMassive | - | 12 | - | 40 | |
Hepatic encephalopathy | - | 17 | - | Ļ2 = 23.721* | <ā0.001* |
Total bilirubin (mg/dl) | |||||
āMin.-Max. | 0.20ā1.40 | 0.50ā9.0 | 0.80ā1.20 | H = 29.980* | <ā0.001* |
Serum albumin (g/dl) | |||||
āMin.-Max. | 3.50ā4.30 | 1.60ā3.0 | 4.0ā5.50 | F = 245.85* | <ā0.001* |
INR | |||||
āMin.-Max. | 0.80ā1.50 | 1.10ā2.50 | 0.90ā1.40 | F = 45.043* | <ā0.001* |
CRP | |||||
āMin.-Max. | 10.0ā18.0 | 24.0ā50.0 | 1.0ā5.0 | H = 69.618* | <ā0.001* |
Child-Pugh Classification | |||||
āA | 30 | 0 | NA | Ļ2 = 60.00* | <ā0.001* |
āB | 0 | 15 | |||
āC | 0 | 15 | |||
MELD/Na score | |||||
āMin-Max | 6.0ā18.0 | 10.0ā30.0 | NA | t = 10.592* | <ā0.001* |
āMean Ā± SD | 10.43 Ā± 3.07 | 20.23 Ā± 4.03 | |||
āMedian (IQR) | 10.0 (9.0ā12.0) | 20.0 (18.0ā22.0) | |||
Serum Leukotriene B4 (ng/L) | |||||
āMin.-Max | 9.11ā58.73 | 13.62ā346.1 | 6.21ā47.45 | H = 11.517* | 0.003* |
āMean Ā± SD | 21.12 Ā± 11.0 | 47.34 Ā± 65.18 | 19.83 Ā± 13.17 | ||
āMedian (IQR) | 17.90(12.63ā28.69) | 24.27(19.59ā39.35) | 13.11(9.13ā27.23) |